[
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock rises Friday, outperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock rises Friday, outperforms market",
    "url": "https://finnhub.io/api/news?id=bbdd2de044a4a7f9923ce1a55442a1fdbb5a85d5ac2ea5aaa5d0bcaade9c13eb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754670900,
      "headline": "Thermo Fisher Scientific Inc. stock rises Friday, outperforms market",
      "id": 136297658,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock rises Friday, outperforms market",
      "url": "https://finnhub.io/api/news?id=bbdd2de044a4a7f9923ce1a55442a1fdbb5a85d5ac2ea5aaa5d0bcaade9c13eb"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher: The Rerating Is Just Getting Started - Buy",
    "summary": "Discover why Thermo Fisher is a Strong Buy with solid fundamentals, organic growth, and up to 48% upside potential. Click here to read my most recent analysis.",
    "url": "https://finnhub.io/api/news?id=f58f42d0c7cd0870be7c77beed3a3f7aa593b8e11db3d38d1da15d0c8c9380eb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754669352,
      "headline": "Thermo Fisher: The Rerating Is Just Getting Started - Buy",
      "id": 136272560,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1477946972/image_1477946972.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Discover why Thermo Fisher is a Strong Buy with solid fundamentals, organic growth, and up to 48% upside potential. Click here to read my most recent analysis.",
      "url": "https://finnhub.io/api/news?id=f58f42d0c7cd0870be7c77beed3a3f7aa593b8e11db3d38d1da15d0c8c9380eb"
    }
  },
  {
    "ts": null,
    "headline": "Microtome Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Fully Automated Microtomes to Drive Market Growth with Advanced Diagnostic Capabilities",
    "summary": "The global microtome market is projected to grow at a 6.13% CAGR from 2025 to 2032, driven by rising chronic disease cases like cancer, cardiovascular diseases, and increased R&D activities. North America leads due to cutting-edge medical infrastructure and high incidence of diseases. Key players include Thermo Fisher, Leica Biosystems, and Sakura Finetek. Fully automated microtomes, pivotal for precise tissue sectioning, are expected to dominate the market, essential for diagnostics and researc",
    "url": "https://finnhub.io/api/news?id=cf3880a6008a06c0d95953f30d725d603bb1fa51fdfc7119c86dd5cda33d8219",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754665740,
      "headline": "Microtome Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Fully Automated Microtomes to Drive Market Growth with Advanced Diagnostic Capabilities",
      "id": 136276380,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The global microtome market is projected to grow at a 6.13% CAGR from 2025 to 2032, driven by rising chronic disease cases like cancer, cardiovascular diseases, and increased R&D activities. North America leads due to cutting-edge medical infrastructure and high incidence of diseases. Key players include Thermo Fisher, Leica Biosystems, and Sakura Finetek. Fully automated microtomes, pivotal for precise tissue sectioning, are expected to dominate the market, essential for diagnostics and researc",
      "url": "https://finnhub.io/api/news?id=cf3880a6008a06c0d95953f30d725d603bb1fa51fdfc7119c86dd5cda33d8219"
    }
  },
  {
    "ts": null,
    "headline": "Agilent: A Lean, Focused Play In Life Sciences Tools Amid Tariff Turbulence",
    "summary": "Agilent remains a strong life science leader with solid financials and strategic resilience, but near-term headwinds temper upside. See why A stock is a hold.",
    "url": "https://finnhub.io/api/news?id=cb5ed25640a6ecd310d6e9800b63a4d642c5006335cc918e2aaec265e971e12f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754637007,
      "headline": "Agilent: A Lean, Focused Play In Life Sciences Tools Amid Tariff Turbulence",
      "id": 136265607,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1206035004/image_1206035004.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Agilent remains a strong life science leader with solid financials and strategic resilience, but near-term headwinds temper upside. See why A stock is a hold.",
      "url": "https://finnhub.io/api/news?id=cb5ed25640a6ecd310d6e9800b63a4d642c5006335cc918e2aaec265e971e12f"
    }
  }
]